(Q37794618)

23 August 2017

title

Infections due to human herpesvirus 6 in solid organ transplant recipients (English)

1 reference

23 August 2017

human herpesvirus 6

1 reference

Raymund R. Razonable

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20881490

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20881490

23 July 2024

publication date

1 December 2010

1 reference

full work available at URL

23 August 2017

https://journals.lww.com/10.1097/MOT.0b013e3283404325

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Current opinion in organ transplantation

23 July 2024

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

671-675

1 reference

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus 6 infections after liver transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Update on human herpesvirus 6 biology, clinical features, and therapy

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus-6 infection after liver transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Clinical impact of human herpesvirus 6 infection after liver transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus-6 antigenemia after liver transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Opportunistic Infections in 547 Organ Transplant Recipients Receiving Alemtuzumab, a Humanized Monoclonal CD-52 Antibody

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

HHV-6A in syncytial giant-cell hepatitis.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Pretransplant human herpesvirus 6 infection of patients with acute liver failure is a risk factor for posttransplant human herpesvirus 6 infection of the liver

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Variant B human herpesvirus-6 associated febrile dermatosis with thrombocytopenia and encephalopathy in a liver transplant recipient

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Herpesvirus 6 Variant A Infection After Heart Transplantation with Giant Cell Transformation in Bile Ductular and Gastroduodenal Epithelium

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Case report: human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesviruses 6 and 7 in solid organ transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

CMV infection is usually associated with concurrent HHV-6 and HHV-7 antigenemia in liver transplant patients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human beta-herpesvirus interactions in solid organ transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus 6 in bronchalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome?

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus 6 infection in adult living related liver transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Human herpesvirus 6 infection in normal human brain tissue.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Influence of ganciclovir prophylaxis on citomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

Comparison of antiviral compounds against human herpesvirus 6 and 7.

23 July 2024

1 reference

https://api.crossref.org/works/10.1097/MOT.0B013E3283404325

23 July 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference